1. Home
  2. BIRK vs PCVX Comparison

BIRK vs PCVX Comparison

Compare BIRK & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$41.38

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$45.47

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIRK
PCVX
Founded
1774
2013
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
6.1B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
BIRK
PCVX
Price
$41.38
$45.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
7
Target Price
$65.50
$101.67
AVG Volume (30 Days)
3.0M
1.5M
Earning Date
12-18-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
83.10
N/A
EPS
2.19
N/A
Revenue
$2,460,904,611.00
N/A
Revenue This Year
$14.52
N/A
Revenue Next Year
$14.40
N/A
P/E Ratio
$18.80
N/A
Revenue Growth
16.22
N/A
52 Week Low
$38.16
$27.66
52 Week High
$62.66
$93.77

Technical Indicators

Market Signals
Indicator
BIRK
PCVX
Relative Strength Index (RSI) 43.81 48.37
Support Level $41.98 $42.40
Resistance Level $43.02 $48.65
Average True Range (ATR) 1.70 1.50
MACD -0.45 0.05
Stochastic Oscillator 15.59 47.85

Price Performance

Historical Comparison
BIRK
PCVX

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: